The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer
Authors:
- 1 January 2019
- journal article
- research article
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 111 (7) , 537-542
Abstract
Objective: the administration of adjuvant chemotherapy after a curative resection is accepted as the standard treatment to improve the prognosis of advanced gastric cancer. Nevertheless, the prognosis of recurrence-related gastric cancer is still not clinically satisfactory. We aimed to assess the therapeutic yield of a radical gastrectomy with D2 lymphadenectomy (RO resection) and the completion of adjuvant chemotherapy. The predictive risk factors for recurrence were also assessed. Methods: a retrospective cohort study was designed with patients diagnosed with advanced gastric cancer. Patients with an R0 resection who had completed adjuvant chemotherapy were included in the study. Results: data from 130 patients who had undergone an RO resection and had completed six cycles of adjuvant chemotherapy were analyzed. The chemotherapy compliance rate was 63.11% and the overall recurrence rate was 36.9%. The lymph node ratio (LNR), which was defined as the number of metastatic lymph nodes divided by the retrieved lymph nodes, was a significant risk factor in the lymph node-positive group (p < 0.01). This parameter had a relatively high sensitivity to predict recurrence compared with the 7th and 8th edition of the AJCC staging system, with an area under the curve of 0.735 (95% confidence interval: 0.6390.832). Baseline CA19-9 level was a risk factor in the lymph node-negative group (p = 0.01). Conclusions: LNR and baseline CA19-9 levels, as simple markers, had strong predictive values for the recurrence of advanced gastric cancer. With regard to recurrence, more potent adjuvant therapy should be considered in high-risk patients.Keywords
This publication has 38 references indexed in Scilit:
- Long-term results of gastrectomy for α-fetoprotein-producing gastric cancerBritish Journal of Surgery, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- The significances of lymph node micrometastasis and its correlation with E‐cadherin expression in pT1‐T3N0 gastric adenocarcinomaJournal of Surgical Oncology, 2007
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of LymphadenectomyAnnals of Surgery, 2007
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerNew England Journal of Medicine, 2006
- Prospective study of peritoneal recurrence after curative surgery for gastric cancerBritish Journal of Surgery, 2003
- Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 2000
- Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patientsCancer, 1994
- CA72-4 compared with carcinoembryonic antigen as a tumour marker for gastric cancerEuropean Journal of Cancer, 1992